SIBO and celiac disease: how often it is found and what testing shows

Short answer

A 2022 pooled analysis of 14 studies put small intestinal bacterial overgrowth (SIBO) at 18.3% of people with celiac disease, with substantial heterogeneity and low-quality evidence1, 2. Ongoing gluten exposure and other conditions are checked as well3, 4, and the breath tests used to look for SIBO have limited accuracy5, 2.

Published by Gluten Verdict · updated · 10 sources, each linked below

Reviewed by Mark Peter, Registered dietitian (RD), on

Coffee mug resting on the corner of a paper slip on a rainy cafe table

Key points

  • Two systematic reviews pooled SIBO in celiac disease at 18.3% (14 studies, 2022) and 20% (11 articles, 2017); each team points to heterogeneity among the studies as a limit1, 2, 6, 7.
  • The National Celiac Association and Coeliac UK name gluten exposure as the most common or usual reason for ongoing symptoms, and the ACG’s 2023 celiac guideline lists it alongside a functional disorder and selective testing for SIBO and other conditions in the work-up of persistent symptoms8, 9, 4.
  • No single symptom is specific to SIBO, and its symptoms overlap those of celiac disease10, 11.
  • The ACG SIBO guideline cites sensitivity of 20% to 93% for glucose breath tests and 31% to 68% for lactulose breath tests against small-bowel cultures12.
  • SIBO frequently recurs after antibiotics, and the ACG says retreatment rests on anecdotal evidence and expert opinion13. Treatment is the gastroenterologist’s decision; this page gives no doses.

What SIBO is

The American College of Gastroenterology (ACG) defines small intestinal bacterial overgrowth as the presence of excessive numbers of bacteria in the small bowel, causing gastrointestinal symptoms14.

Its guideline names abdominal pain, bloating, gas, distension, flatulence and diarrhea as the most common symptoms reported by people with SIBO15. It also says that no single symptom can be specifically attributed to SIBO10.

The guideline lists celiac disease among the conditions where SIBO is known to occur16. NIDDK’s treatment page for celiac disease names SIBO among the health problems that cause symptoms similar to those of celiac disease and may occur along with it17.

How often is SIBO found in celiac disease?

Two systematic reviews have pooled studies of SIBO in celiac disease. Their figures are close but not the same, and both teams point to heterogeneity among the studies as a limit2, 7.

Two pooled analyses of SIBO in celiac disease, as each paper reports its own figures
Shah and colleagues, 2022Losurdo and colleagues, 2017
What was pooled14 studies: 742 people with celiac disease and 178 controls111 articles6
SIBO in people with celiac disease, all studies18.3% (95% CI 11.4–28.1), substantial heterogeneity120% (95% CI 10%–30%)6
Found by breath test20.8% (95% CI 11.9–33.7)1823% (95% CI 10%–37%)19
Found by culture of a small-bowel sample12.6% (95% CI 5.1–28.0)1811% (95% CI 3%–19%)19
People not responding to the gluten-free diet (2022) or symptomatic despite it (2017)17.1% (95% CI 9.5–28.7)2028% (95% CI 10%–47%)21
Compared with people who responded to the diet or had no symptomsNot statistically higher (OR 1.5, 95% CI 0.4–5.0, P = 0.511)2210% in people without symptoms (95% CI 3%–16%); the difference was not statistically significant (P=.06)21

Shah and colleagues rate the overall quality of the evidence as low, mainly because of substantial clinical heterogeneity and the limited sensitivity and specificity of the available tests2. Losurdo and colleagues conclude that the heterogeneity of the studies may not support a relationship between SIBO and celiac disease, while adding that SIBO could be more common when symptoms do not improve on the diet7.

Compared with healthy controls, the 2022 review found SIBO significantly more often in people with celiac disease (OR 5.1, 95% CI 2.1–12.4) in the case-control studies that used healthy controls23. SIBO overlaps with other gastrointestinal disorders, and it is often unclear whether it is the cause, a consequence or an epiphenomenon24.

Breath testing found more SIBO than culture in both reviews18, 19, and each method has known weaknesses: culture of a small-bowel sample is invasive, prone to contamination, and its best cut-off values are disputed25; breath tests are discussed below.

Shah and colleagues report that none of the studies they pooled looked at methane-positive SIBO in celiac disease26, or controlled for the effect of proton-pump inhibitor use27.

Why the symptoms overlap

NIDDK lists bloating, chronic diarrhea, constipation, gas and abdominal pain among the digestive symptoms of celiac disease28. Bloating, diarrhea, gas and abdominal pain also appear on the ACG guideline’s list of the most common symptoms in SIBO15, and the 2022 review opens by noting that symptoms of the two conditions often overlap11.

The ACG guideline adds that SIBO symptoms often masquerade as other diagnoses such as IBS, functional diarrhea, functional dyspepsia or bloating29. That is why this page offers no symptom checklist for telling the two apart.

What else is checked when symptoms persist

Persistent symptoms on a gluten-free diet have a name. The ACG defines nonresponsive celiac disease as persistent or recurrent symptoms despite being on a gluten-free diet3. NIDDK says that in about 20 percent of people with celiac disease symptoms continue or come back on the diet30; Coeliac UK says ongoing symptoms affect around 1 in 3 people9. Those figures differ, and each is its publisher’s own.

Several sources single out gluten exposure. The National Celiac Association calls accidental or intentional gluten exposure the most common reason8; Coeliac UK says that most of the time gluten is still getting into the diet9; Beyond Celiac says that even when bacterial overgrowth and lactose intolerance are excluded, a seemingly strict diet can inadvertently include enough gluten to trigger symptoms or damage31; and the ACG’s 2023 guideline singles out unintentional gluten contamination3.

The 2023 ACG celiac guideline lists these parts of the evaluation of persistent or recurrent symptoms4:

  • Reviewing and confirming the initial diagnosis of celiac disease4.
  • Evaluating for inadvertent gluten exposure, through assessment by an expert dietitian and serology4.
  • Assessing for a coexisting functional disorder4.
  • Selective testing, based on clinical suspicion, for food intolerances (lactose, fructose), pancreatic insufficiency, microscopic colitis and small intestinal bacterial overgrowth, among others4.

NIDDK suggests keeping a food journal and talking with a doctor and a registered dietitian about diet and the products used that might contain gluten32. Our pages on hidden sources of gluten, food and symptom diaries, non-responsive celiac disease and lactose intolerance in celiac disease go further.

Not every charity page names SIBO. Coeliac UK’s page on non-responsive coeliac disease mentions irritable bowel syndrome and lactose intolerance as other causes to consider, and does not mention SIBO33. The National Celiac Association and NIDDK both do name it34, 17.

How a breath test works, and where it falls short

The ACG guideline says breath samples should be measured for hydrogen and methane35. It explains that human cells are incapable of producing these gases, so finding them in a breath sample points to fermentation of carbohydrate by microbes in the gut36. The sugars traditionally used to trigger the test are glucose and lactulose37.

The ACG calls the test an indirect method of assessing whether there are excessive amounts of bacteria in the small bowel38, and says the current breath tests have low sensitivity and specificity and need further validation5.

Accuracy ranges the ACG guideline cites from a systematic review, compared with cultures of small-bowel samples
Sugar usedSensitivitySpecificityCriticism the guideline records
Lactulose31 to 68 percent1244 to 100 percent12High false-positive values, because of faster transit and colonic fermentation in some people39
Glucose20 to 93 percent1230 to 86 percent12Absorbed in the proximal duodenum, so low sensitivity for overgrowth in the distal small bowel39

The definition of a positive test matters too. In a randomized trial of rifaximin in celiac disease with persistent symptoms, an abnormal lactulose breath test was defined in two ways, and SIBO was present at baseline in 55% of patients by the first definition and 8% by the second40, 41. The trial’s authors concluded that hydrogen breath tests do not reliably identify who will respond to antibiotic therapy42.

Preparation affects the result. The ACG guideline summarizes the North American Consensus: avoid antibiotics for 4 weeks beforehand and promotility agents and laxatives for at least 1 week, avoid fermentable foods the day before, and fast for 8 to 12 hours43. This is the ACG’s summary of one consensus article, not a clinic’s instructions.

For tests done at home, the guideline notes that diet precautions, sugar ingestion and sample collection happen in a home setting that may not be strictly controlled44.

A methane reading is a special case. Methane is made by archaea, not bacteria, so the ACG authors propose calling methane overgrowth intestinal methanogen overgrowth (IMO) rather than SIBO45.

The ACG guideline’s six numbered recommendations cover breath testing in people with IBS, suspected motility disorders, previous abdominal surgery and constipation (for methane), a suggestion against testing asymptomatic people on proton-pump inhibitors, and antibiotics for symptomatic people with SIBO. None names celiac disease, and all six are conditional recommendations with very low or low levels of evidence46.

What the sources say about treatment and recurrence

Which antibiotic, how long and whether to repeat it are for the gastroenterologist, and this page gives no doses. What the sources report:

  • The ACG guideline says that because antibiotic use carries consequences such as resistant bacteria, adverse reactions and infection with Clostridioides difficile, an effort should be made to diagnose SIBO objectively before antibiotics are considered47.
  • It describes the evidence for antibiotics in SIBO as limited to small clinical trials of poor to modest quality48, and suggests antibiotics for symptomatic patients with SIBO as a conditional recommendation with a low level of evidence49.
  • In celiac disease, the 2022 review found four studies reporting on 23 people with SIBO who took antibiotics; symptoms improved in 22 of the 23 (95.6%, 95% CI 78.0–99.9)50, 51. The numbers are small, and the review rates its overall evidence as low2.
  • A randomized, placebo-controlled trial of rifaximin in 50 people with celiac disease and persistent symptoms found that symptom scores were unaffected by treatment, regardless of baseline breath tests52, 53.
  • The ACG says SIBO frequently recurs after a course of antibiotics, that retreatment is common practice but based solely on anecdotal evidence and expert opinion, and that no treatment approach is universally accepted13. One study it cites, of 80 adults, found recurrence in 12.6% at 3 months, 27.5% at 6 months and 43.7% at 9 months54.

The pooled antibiotic data and the randomized trial point in different directions. This page does not try to reconcile them; the gastroenterologist weighs them for the individual.

Diets and supplements sold for SIBO

The ACG guideline says the data on diet for SIBO are principally extensions of the data from IBS. It cites an IBS meta-analysis that found no good evidence to support gluten-free approaches and “very low quality evidence” for low FODMAP diets55. That finding is about IBS; for celiac disease, the ACG’s 2023 guideline says current treatment requires strict adherence to a gluten-free diet and lifelong medical follow-up56. See also our page on low FODMAP and gluten-free eating.

On probiotics, the ACG describes a meta-analysis in which probiotics appeared to reduce hydrogen production, but the studies were mostly small and of poor quality57. It also cites one controlled study reporting that probiotics may cause SIBO and D-lactic acidosis leading to gas and bloating58. See also probiotics and celiac disease.

This page does not rate products or diets sold for SIBO.

Questions to bring to the gastroenterologist

These are prompts for the visit, not medical advice; your gastroenterologist decides what applies. More in our guide to questions for your gastroenterologist.

  • Has my gluten exposure been reviewed with a dietitian, and have my celiac antibody results been checked?
  • Is my celiac disease diagnosis confirmed, and does my biopsy history support it?
  • Which other conditions, such as lactose intolerance, microscopic colitis, pancreatic insufficiency or irritable bowel syndrome, could fit my symptoms, alone or together with SIBO?
  • If a breath test is suggested: which sugar will be used, what preparation applies, will methane be measured, and what would a positive or a negative result change?
  • Do any medicines I take, such as acid-reducing ones, affect how the result should be read?
  • If SIBO is found and treated, what is the plan if symptoms return?

Questions people ask

Can celiac disease cause SIBO?

A 2022 meta-analysis found SIBO significantly more often in people with celiac disease than in healthy controls in the case-control studies that used them23, but the review notes that SIBO overlaps with other gastrointestinal disorders, often making it unclear whether it is the cause, a consequence or an epiphenomenon24, and the review rates its evidence as low quality2.

Is SIBO more common if I still have symptoms on a gluten-free diet?

The two pooled reviews report it differently. One found 28% in people with continuing symptoms against 10% in people without, a difference that was not statistically significant21. The other found SIBO not statistically higher in people who did not respond to the diet than in those who did22.

Does a negative breath test rule SIBO out?

The ACG guideline says current breath tests have low sensitivity and specificity5, and cites sensitivities as low as 20% for glucose breath tests and 31% for lactulose against small-bowel culture12. It also notes that the glucose test can miss overgrowth in the distal small bowel39. What a result means for one person is for the gastroenterologist to judge.

Does rifaximin work for SIBO in celiac disease?

One randomized trial in people with celiac disease and persistent symptoms found symptom scores unaffected by rifaximin53, while a pooled analysis of four studies covering 23 people reported symptom improvement in 22 of them who took antibiotics50, 51. The ACG describes the evidence for antibiotics in SIBO as small trials of poor to modest quality48.

More in Related conditions and complications

Sources